Biocceleration

Company Overview

Snapshot

Founded in January 2003, Biocceleration operates with 11–50 employees. The company's status changed to Non Active in August 2017.

Business overview

Biocceleration is a bioinformatics company specializing in hardware accelerators and software packages designed to expedite searches in protein and nucleic acid databases. The company's core technology significantly accelerates rigorous database search algorithms, such as HMMsearch and Smith-Waterman, by factors of 10 to 1,000 compared to general-purpose servers. Biocceleration operates within the Health Tech & Life Sciences sector, serving markets that require high-speed bioinformatics processing.

Company Intelligence Q&A

What is Biocceleration's primary focus?

Biocceleration focuses on bioinformatics, providing hardware accelerators and software for accelerating searches in protein and nucleic acid databases.

When was Biocceleration founded?

Biocceleration was founded in January 2003.

What is the status of Biocceleration?

Biocceleration became Non Active in August 2017.

What kind of acceleration does Biocceleration offer for database searches?

Biocceleration can accelerate rigorous database search algorithms like HMMsearch and Smith-Waterman by a factor of 10-1,000 relative to general purpose servers.

What products does Biocceleration offer?

Biocceleration offers products including BioXL/H, GenWeb, and GenCore.